Resezione chirurgica di un tumore stromale gastrointestinale dopo trattamento con imatinib: un caso clinico.

S. Baldo; M. Rivoire; A. Sobrero; D. Comandini; D. Civalleri; M. Stella; F. Quaglia; R. Santoni; M. Malerba; F. Mariani; F. DeCian

Resezione chirurgica di un tumore stromale gastrointestinale dopo trattamento con imatinib: un caso clinico.

Translated title of the contribution: Surgical resection of gastrointestinal stromal tumor after treatment with imatinib: clinical case

S. Baldo, M. Rivoire, A. Sobrero, D. Comandini, D. Civalleri, M. Stella, F. Quaglia, R. Santoni, M. Malerba, F. Mariani, F. DeCian

A.O.U. San Martino - IST, Istituto Nazionale Ricerca sul Cancro (GENOVA)

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The stromal tumor is the most common mesenchymal tumor of the gastrointestinal tract. Surgical resection is the first-line therapy for operable lesions, however for inoperable imatinib is an effective therapy. In this setting a patient has been operated after a remarkable response to imatinib, used as both neoadjuvant and adjuvant. This approach led to a disease-free condition without toxicity and complications.

Translated title of the contribution	Surgical resection of gastrointestinal stromal tumor after treatment with imatinib: clinical case
Original language	Italian
Title of host publication	I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.]
Volume	4
Edition	3
Publication status	Published - 2005

Cite this

Baldo, S., Rivoire, M., Sobrero, A., Comandini, D., Civalleri, D., Stella, M., Quaglia, F., Santoni, R., Malerba, M., Mariani, F., & DeCian, F. (2005). Resezione chirurgica di un tumore stromale gastrointestinale dopo trattamento con imatinib: un caso clinico. In I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.] (3 ed., Vol. 4)

@inbook{a9d59e5f86994eaa83aabcd57755cf04,

title = "Resezione chirurgica di un tumore stromale gastrointestinale dopo trattamento con imatinib: un caso clinico.",

abstract = "The stromal tumor is the most common mesenchymal tumor of the gastrointestinal tract. Surgical resection is the first-line therapy for operable lesions, however for inoperable imatinib is an effective therapy. In this setting a patient has been operated after a remarkable response to imatinib, used as both neoadjuvant and adjuvant. This approach led to a disease-free condition without toxicity and complications.",

author = "S. Baldo and M. Rivoire and A. Sobrero and D. Comandini and D. Civalleri and M. Stella and F. Quaglia and R. Santoni and M. Malerba and F. Mariani and F. DeCian",

year = "2005",

language = "Italian",

volume = "4",

booktitle = "I supplementi di Tumori : official journal of Societ{\`a} italiana di cancerologia ... [et al.]",

edition = "3",

}

TY - CHAP

T1 - Resezione chirurgica di un tumore stromale gastrointestinale dopo trattamento con imatinib

T2 - un caso clinico.

AU - Baldo, S.

AU - Rivoire, M.

AU - Sobrero, A.

AU - Comandini, D.

AU - Civalleri, D.

AU - Stella, M.

AU - Quaglia, F.

AU - Santoni, R.

AU - Malerba, M.

AU - Mariani, F.

AU - DeCian, F.

PY - 2005

Y1 - 2005

N2 - The stromal tumor is the most common mesenchymal tumor of the gastrointestinal tract. Surgical resection is the first-line therapy for operable lesions, however for inoperable imatinib is an effective therapy. In this setting a patient has been operated after a remarkable response to imatinib, used as both neoadjuvant and adjuvant. This approach led to a disease-free condition without toxicity and complications.

AB - The stromal tumor is the most common mesenchymal tumor of the gastrointestinal tract. Surgical resection is the first-line therapy for operable lesions, however for inoperable imatinib is an effective therapy. In this setting a patient has been operated after a remarkable response to imatinib, used as both neoadjuvant and adjuvant. This approach led to a disease-free condition without toxicity and complications.

UR - http://www.scopus.com/inward/record.url?scp=33644871201&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644871201&partnerID=8YFLogxK

M3 - Capitolo

C2 - 16437930

AN - SCOPUS:33644871201

VL - 4

BT - I supplementi di Tumori : official journal of Società italiana di cancerologia ... [et al.]

ER -

Resezione chirurgica di un tumore stromale gastrointestinale dopo trattamento con imatinib: un caso clinico.

Abstract

Other files and links

Fingerprint

Cite this